Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2030

Conditions
GlioblastomaBrain Tumor, PrimaryBrain Tumor - Metastatic
Interventions
RADIATION

Intraoperative Radiation Therapy in Malignant Cerebral Tumor

This technique can fully expose the tumor bed during the operation, and pull the brain tissue around the tumor under the microscope to de-radiation, so as to exceed the total dose level of standard conformal conventional external radiation therapy (EBRT), maximize the radiobiological effect of a single high-dose irradiation, and deliver precise radiation to the tumor bed, while minimizing the radiation dose of peripheral nerve tissue. This technique is also a good choice for patients with orthotopic recurrent tumors who can no longer tolerate one more EBRT. Intraoperative radiotherapy technology can reduce the chance of postoperative tumor recurrence and improve the survival and prognosis of patients by providing a higher effective total dose to the tumor bed, while promoting dose escalation without significantly increasing the occurrence of complications in normal tissues, and improving the local control rate.

All Listed Sponsors
lead

First Affiliated Hospital, Sun Yat-Sen University

OTHER

NCT06929819 - Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor | Biotech Hunter | Biotech Hunter